Skip to content

Collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for the improvement of erectile function in men with diabets

Collagen scaffolds loaded with human umbilical cord mesenchymal stem cells for the improvement of erectile function in men with diabets

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCN-15007041
Enrollment
Unknown
Registered
2015-09-05
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic erectile dysfunction

Interventions

the Patients with Diabetic Erectile Dysfunction:hUC-MSC injection to the Corpus Cavernosum
the Patients with Diabetic Erectile Dysfunction:Collagen Scaffolds Loaded with hUC-MSC injection to the Corpus Cavernosum

Sponsors

Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. type 1 or 2 diabetes,blood glucose controlled well, no effective with oral pde-5i; 2. have a consistent partner who is willing to engage in sexual activity more than twice per month during the study; 3. males age 20 65 years; 4. iief, ef(erectile function) domain score is under 16; 5. penile arterial insufficiency or venous leakage (doppler) at the time o inclusion: psv 25 cm/sec, edv>5cm/sec, ri<0, 75; 6. hba1c is between 6.5% 10%; 7. physical examination with no abnormalities; 8. who is willing to consent to participate in the study follow-up; 9. willing to limit alcohol intake eliminate use of recreational drugs for sexual encounters.

Exclusion criteria

Exclusion criteria: 1. severe cardiovascular disease(angina, arrhythmia, cardiac failure, stroke), kidney failure, respiratory failure; history of malignancy; 2. positive for human immunodeficiency virus (hiv), hepatitis b virus (hbv), hepatitis c virus (hcv) syphilis test; 3. testosterone level is less than 200ng/dl; 4. serum ast/alt >3*upper limit of normal or creatinine >1.5*upper limit of normal; 5. hba1c exhibit greater than 10%; 6. in the investigators judgment, with clinical significance of penis abnormalities, or has received penile prosthesis implantation surgery; 7. patients partner is trying to conceive during the trial period; 8. exposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study; 9. unwilling and/or not able to give written informed consent.

Design outcomes

Primary

MeasureTime frame
IIEF-5;SEP;GAQ;

Secondary

MeasureTime frame
Penile Doppler;NPT;

Countries

China

Contacts

Public ContactYutian Dai
13913957628@163.com+86 13913957628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026